News & Updates

Show Multimedia Only
Preterm preeclampsia screen-and-prevent strategy to launch across HK’s public hospitals after initial success
Preterm preeclampsia screen-and-prevent strategy to launch across HK’s public hospitals after initial success
27 Aug 2024 byChristina Lau

A screen-and-prevent strategy for preterm preeclampsia (PE), which involves screening in the first trimester and low-dose aspirin prophylaxis for high-risk women in <16–36 weeks of gestation, will be launched in obstetric units of public hospitals across Hong Kong following promising results from a multicentre Asian trial led by the Chinese University of Hong Kong (CUHK) and a pilot programme at the Prince of Wales Hospital (PWH).

Preterm preeclampsia screen-and-prevent strategy to launch across HK’s public hospitals after initial success
27 Aug 2024
GLP-1RAs outperform DPP-4is in preventing hyperkalemia, RASi therapy discontinuation
GLP-1RAs outperform DPP-4is in preventing hyperkalemia, RASi therapy discontinuation
20 Aug 2024 byJairia Dela Cruz

Individuals with type 2 diabetes (T2D) treated in routine clinical care appear to fare better with glucagon-like peptide-1 receptor agonists (GLP-1RAs) than with dipeptidyl peptidase-4 inhibitors (DPP-4is), with GLP-1Ras being associated with lower rates of hyperkalemia and renin-angiotensin system inhibitor (RASi) medication discontinuation, as shown in an observational study.

GLP-1RAs outperform DPP-4is in preventing hyperkalemia, RASi therapy discontinuation
20 Aug 2024
Multiple factors influence risks of cirrhosis, HCC in veterans with MAFLD
Multiple factors influence risks of cirrhosis, HCC in veterans with MAFLD
17 Aug 2024 byStephen Padilla

The incidence of cirrhosis and hepatocellular carcinoma (HCC) among veterans differs according to demographic and clinical characteristics, with the lowest rate seen among Asians, reports a study.

Multiple factors influence risks of cirrhosis, HCC in veterans with MAFLD
17 Aug 2024